These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24853218)

  • 21. Therapeutic effect of bleomycin for skin tumors.
    Takeda K; Sagawa Y; Arakawa T
    Gan; 1970 Jun; 61(3):207-18. PubMed ID: 5455320
    [No Abstract]   [Full Text] [Related]  

  • 22. [Histological findings during the treatment of skin neoplasias with 5-fluorouracil ointment].
    Zala L
    Dermatologica; 1972; 145(5):326-33. PubMed ID: 4654411
    [No Abstract]   [Full Text] [Related]  

  • 23. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
    Tillman DK; Carroll MT
    Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The risk of developing subsequent nonmelanoma skin cancers.
    Schreiber MM; Moon TE; Fox SH; Davidson J
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 1):1114-8. PubMed ID: 2273111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of targeted molecular inhibitors in the management of advanced nonmelanoma skin cancer.
    O'Bryan KW; Ratner D
    Semin Cutan Med Surg; 2011 Mar; 30(1):57-61. PubMed ID: 21540021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New Perspectives in the Pharmacological Treatment of Non-Melanoma Skin Cancer.
    Savoia P; Cremona O; Fava P
    Curr Drug Targets; 2016; 17(3):353-74. PubMed ID: 26245477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecularly targeted therapies for nonmelanoma skin cancers.
    Liu LS; Colegio OR
    Int J Dermatol; 2013 Jun; 52(6):654-65. PubMed ID: 23679874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clearance of basal cell and superficial squamous cell carcinomas after imiquimod therapy.
    Warshauer E; Warshauer BL
    J Drugs Dermatol; 2008 May; 7(5):447-51. PubMed ID: 18505136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and structural evaluation of the treatment of some hyperplastic and neoplastic skin diseases with 5-fluorouracil (5-FU) ointment.
    Binazzi M
    Dermatologica; 1970; 140():Suppl 1:90-6. PubMed ID: 5471369
    [No Abstract]   [Full Text] [Related]  

  • 30. Oral therapy for nonmelanoma skin cancer in patients with advanced disease and large tumor burden: a review of the literature with focus on a new generation of targeted therapies.
    Rudnick EW; Thareja S; Cherpelis B
    Int J Dermatol; 2016 Mar; 55(3):249-58; quiz 256, 258. PubMed ID: 26566923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic cutaneous arsenism treated with aromatic retinoid.
    Thianprasit M
    J Med Assoc Thai; 1984 Feb; 67(2):93-100. PubMed ID: 6736831
    [No Abstract]   [Full Text] [Related]  

  • 32. No chemopreventive effect of nonsteroidal anti-inflammatory drugs on nonmelanoma skin cancer: evidence from meta-analysis.
    Zhang B; Liang X; Ye L; Wang Y
    PLoS One; 2014; 9(5):e96887. PubMed ID: 24828489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients.
    O'Reilly Zwald F; Brown M
    J Am Acad Dermatol; 2011 Aug; 65(2):253-261. PubMed ID: 21763561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycoalkaloids from Solanum sodomaeum are effective in the treatment of skin cancers in man.
    Cham BE; Meares HM
    Cancer Lett; 1987 Aug; 36(2):111-8. PubMed ID: 3621146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review.
    Love WE; Bernhard JD; Bordeaux JS
    Arch Dermatol; 2009 Dec; 145(12):1431-8. PubMed ID: 20026854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unresectable primary facial cutaneous carcinoma.
    Whitaker DC
    J Dermatol Surg Oncol; 1992 Feb; 18(2):125-9. PubMed ID: 1537949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy.
    Fink-Puches R; Soyer HP; Hofer A; Kerl H; Wolf P
    Arch Dermatol; 1998 Jul; 134(7):821-6. PubMed ID: 9681345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years.
    Christenson LJ; Borrowman TA; Vachon CM; Tollefson MM; Otley CC; Weaver AL; Roenigk RK
    JAMA; 2005 Aug; 294(6):681-90. PubMed ID: 16091570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An update on local and systemic therapies for nonmelanoma skin cancer.
    Elleson KM; DePalo DK; Zager JS
    Expert Rev Anticancer Ther; 2022 May; 22(5):479-489. PubMed ID: 35412413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advanced and recurrent nonmelanoma skin cancer.
    Luce EA
    Clin Plast Surg; 1997 Oct; 24(4):731-45. PubMed ID: 9342514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.